Enavate Sciences GP, LLC Q3 2025 Filing

Filed November 14, 2025

Portfolio Value

$327.5B

Holdings

7

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (7 positions)

#StockSharesValue% PortfolioType
1
ZBIOZENAS BIOPHARMA INC
3,761,359$83.5B25.49%
2
SIONSIONNA THERAPEUTICS INC
2,478,030$72.9B22.25%
3
IMNMIMMUNOME INC
4,768,583$55.8B17.05%
4
UPBUPSTREAM BIO INC
2,459,703$46.3B14.13%
5
BBOTBRIDGEBIO ONCOLOGY THERAPEUT
2,626,946$30.4B9.29%
6
CMPXCOMPASS THERAPEUTICS INC
7,788,150$27.3B8.32%
7
CAMPCAMP4 THERAPEUTICS CORP
3,785,802$11.4B3.47%